117 related articles for article (PubMed ID: 36042628)
21. Resveratrol inhibits bile acid-induced gastric intestinal metaplasia via the PI3K/AKT/p-FoxO4 signalling pathway.
Lu W; Ni Z; Jiang S; Tong M; Zhang J; Zhao J; Feng C; Jia Q; Wang J; Yao T; Ning H; Shi Y
Phytother Res; 2021 Mar; 35(3):1495-1507. PubMed ID: 33103284
[TBL] [Abstract][Full Text] [Related]
22. Circ_UBR4 Knockdown Alleviates Oxidized Low-Density Lipoprotein-Provoked Growth and Migration of Human Vascular Smooth Muscle Cells by Acting on the miR-637/FOXO4 Pathway.
Ding Y; Tang T; Lu J; Wang J
J Cardiovasc Pharmacol; 2021 Oct; 78(4):534-543. PubMed ID: 34225339
[TBL] [Abstract][Full Text] [Related]
23. [Cyclo-oxygenase-2 and p53 immunoreactivity in superficial early colorectal carcinoma].
Kim YS; Lim SD; Lee JK; Kim SE; Ryu SH; Lee JW; Moon JS
Korean J Gastroenterol; 2006 May; 47(5):350-6. PubMed ID: 16714876
[TBL] [Abstract][Full Text] [Related]
24. [Expression and clinical significance of FOX04 in colorectal cancer].
Xiang-qiang L; Shan-hong T; Zhi-yong Z; Hai-feng J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):969-71. PubMed ID: 22125836
[TBL] [Abstract][Full Text] [Related]
25. Multiple regulatory intrinsically disordered motifs control FOXO4 transcription factor binding and function.
Bourgeois B; Gui T; Hoogeboom D; Hocking HG; Richter G; Spreitzer E; Viertler M; Richter K; Madl T; Burgering BMT
Cell Rep; 2021 Jul; 36(4):109446. PubMed ID: 34320339
[TBL] [Abstract][Full Text] [Related]
26. Regulation of cellular senescence via the FOXO4-p53 axis.
Bourgeois B; Madl T
FEBS Lett; 2018 Jun; 592(12):2083-2097. PubMed ID: 29683489
[TBL] [Abstract][Full Text] [Related]
27. Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients.
Negi RR; Rana SV; Gupta V; Gupta R; Chadha VD; Prasad KK; Dhawan DK
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1675-1681. PubMed ID: 31244287
[TBL] [Abstract][Full Text] [Related]
28. High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma.
Zheng L; Xie G; Duan G; Yan X; Li Q
PLoS One; 2011; 6(7):e22203. PubMed ID: 21765952
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and prognostic implications of polo-like kinase 1 expression in colorectal cancer: A systematic review and meta-analysis.
Ran Z; Chen W; Shang J; Li X; Nie Z; Yang J; Li N
Gene; 2019 Dec; 721():144097. PubMed ID: 31493507
[TBL] [Abstract][Full Text] [Related]
30. Development of a novel senolytic by precise disruption of FOXO4-p53 complex.
Tripathi U; Chaib S; Gerdes EOW; Hogan KA; Zhu Y
EBioMedicine; 2021 Dec; 74():103693. PubMed ID: 34768086
[No Abstract] [Full Text] [Related]
31. Dihydromyricetin modulates p62 and autophagy crosstalk with the Keap-1/Nrf2 pathway to alleviate ethanol-induced hepatic injury.
Qiu P; Dong Y; Li B; Kang XJ; Gu C; Zhu T; Luo YY; Pang MX; Du WF; Ge WH
Toxicol Lett; 2017 May; 274():31-41. PubMed ID: 28419832
[TBL] [Abstract][Full Text] [Related]
32. hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features.
Lam AK; Ong K; Ho YH
Int J Colorectal Dis; 2008 Jun; 23(6):587-94. PubMed ID: 18322660
[TBL] [Abstract][Full Text] [Related]
33. FOXO4 mediates resistance to oxidative stress in lens epithelial cells by modulating the TRIM25/Nrf2 signaling.
Yang X; Zhang F; Liu X; Meng J; Du S; Shao J; Liu J; Fang M
Exp Cell Res; 2022 Nov; 420(1):113340. PubMed ID: 36075446
[TBL] [Abstract][Full Text] [Related]
34. Expression of long non-coding RNA CCHE1 in colorectal carcinoma: correlations with clinicopathological features and ERK/COX-2 pathway.
Gaballah HH; Gaber RA; Elrashidy MA; Elshahat DA; Hablus MA; Ebeid AM
Mol Biol Rep; 2019 Feb; 46(1):657-667. PubMed ID: 30484108
[TBL] [Abstract][Full Text] [Related]
35. Expression of the EP300, TP53 and BAX genes in colorectal cancer: Correlations with clinicopathological parameters and survival.
Kowalczyk AE; Krazinski BE; Godlewski J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Kiezun J; Sulik M; Kmiec Z
Oncol Rep; 2017 Jul; 38(1):201-210. PubMed ID: 28586030
[TBL] [Abstract][Full Text] [Related]
36. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
[TBL] [Abstract][Full Text] [Related]
37. FoxO4 promotes early inflammatory response upon myocardial infarction via endothelial Arg1.
Zhu M; Goetsch SC; Wang Z; Luo R; Hill JA; Schneider J; Morris SM; Liu ZP
Circ Res; 2015 Nov; 117(11):967-77. PubMed ID: 26438688
[TBL] [Abstract][Full Text] [Related]
38. Small leucine zipper protein functions as a modulator for metabolic reprogramming of colorectal cancer cells by inducing nutrient stress-mediated autophagy.
Kim S; Oh M; Kang M; Ko J
Cell Mol Life Sci; 2022 Sep; 79(9):505. PubMed ID: 36057892
[TBL] [Abstract][Full Text] [Related]
39. FOXO4 Transactivation Domain Interaction with Forkhead DNA Binding Domain and Effect on Selective DNA Recognition for Transcription Initiation.
Kim J; Ahn D; Park CJ
J Mol Biol; 2021 Feb; 433(4):166808. PubMed ID: 33450250
[TBL] [Abstract][Full Text] [Related]
40. FoxO4 inhibits NF-kappaB and protects mice against colonic injury and inflammation.
Zhou W; Cao Q; Peng Y; Zhang QJ; Castrillon DH; DePinho RA; Liu ZP
Gastroenterology; 2009 Oct; 137(4):1403-14. PubMed ID: 19560465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
